{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:30:49Z","timestamp":1788406249748,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T00:00:00Z","timestamp":1671148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jpeds.2022.12.016","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T20:08:52Z","timestamp":1671566932000},"page":"113-119.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Ferric Carboxymaltose Versus Ferrous Fumarate in Anemic Children with Inflammatory Bowel Disease: The POPEYE Randomized\u00a0Controlled Clinical\u00a0Trial"],"prefix":"10.1016","volume":"256","author":[{"given":"Nanja","family":"Bevers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"Van de Vijver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arta","family":"Aliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashkan","family":"Rezazadeh Ardabili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rosias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke","family":"Stapelbroek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imke A.","family":"Bertrams Maartens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathelijne","family":"van de Feen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hankje","family":"Escher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Oudshoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Teklenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Vande Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjorn","family":"Winkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Raijmakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Vreugdenhil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke J.","family":"Pierik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick F.","family":"van Rheenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2022.12.016_bib1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ibd.21740","article-title":"Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease","volume":"18","author":"Goodhand","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jpeds.2022.12.016_bib2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/MPG.0000000000002885","article-title":"Anemia in children with inflammatory bowel disease: a position paper by the IBD Committee of the North American Society of pediatric Gastroenterology, Hepatology and nutrition","volume":"71","author":"Goyal","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jpeds.2022.12.016_bib3","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1097\/MIB.0b013e31829ed855","article-title":"The epidemiology of anemia in pediatric inflammatory bowel disease: prevalence and associated factors at diagnosis and follow-up and the impact of exclusive enteral nutrition","volume":"19","author":"Gerasimidis","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jpeds.2022.12.016_bib4","first-page":"517","article-title":"Improvement of health-related quality of life in children with inflammatory bowel disease receiving routine intravenous iron supplementation","volume":"24","author":"Danko","year":"2019","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.jpeds.2022.12.016_bib5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrgastro.2010.151","article-title":"Diagnosis and management of iron deficiency anemia in patients with IBD","volume":"7","author":"Stein","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jpeds.2022.12.016_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ecco-jcc\/jju009","article-title":"European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases","volume":"9","author":"Dignass","year":"2015","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jpeds.2022.12.016_bib7","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/01.mib.0000235097.86360.04","article-title":"Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation","volume":"12","author":"Semrin","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jpeds.2022.12.016_bib8","series-title":"Responses of the gut microbiota to supplementary iron: a survey at the host -microbial interface [dissertation]","author":"Kortman","year":"2014"},{"key":"10.1016\/j.jpeds.2022.12.016_bib9","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/1574-6976.12086","article-title":"Nutritional iron turned inside out: intestinal stress from a gut microbial perspective","volume":"38","author":"Kortman","year":"2014","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.jpeds.2022.12.016_bib10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1471-230X-14-184","article-title":"Effectiveness and safety of ferric carboxymaltose treatment in children and adolescents with inflammatory bowel disease and other gastrointestinal diseases","volume":"14","author":"Laass","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jpeds.2022.12.016_bib11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jpeds.2016.09.053","article-title":"Intravenous ferric carboxymaltose in children with iron deficiency anemia who respond poorly to oral iron","volume":"180","author":"Powers","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2022.12.016_bib12","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.dld.2021.02.017","article-title":"Ferric carboxymaltose treatment for iron deficiency anemia in children with inflammatory bowel disease: efficacy and risk of hypophosphatemia","volume":"53","author":"Cococcioni","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jpeds.2022.12.016_bib13","series-title":"Ferinject (ferric carboxymaltose) - summary of product characteristics, the electronic Medicines Compendium [Internet]","year":"2020"},{"key":"10.1016\/j.jpeds.2022.12.016_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"8","author":"Schulz","year":"2010","journal-title":"BMC Med"},{"key":"10.1016\/j.jpeds.2022.12.016_bib15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/MPG.0000000000000239","article-title":"ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents","volume":"58","author":"Levine","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jpeds.2022.12.016_bib16","series-title":"Iron deficiency anemia: assessment, prevention and control. Report of a joint WHO\/UNICEF\/UNU consultation","year":"2001"},{"key":"10.1016\/j.jpeds.2022.12.016_bib17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00431-020-03597-5","article-title":"Diagnosis and management of iron deficiency in children with or without anemia: consensus recommendations of the SPOG Pediatric Hematology Working Group","volume":"179","author":"Mattiello","year":"2020","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jpeds.2022.12.016_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2017-000074","article-title":"Laboratory reference intervals in the assessment of iron status in young children","volume":"1","author":"Parkin","year":"2017","journal-title":"BMJ Paediatr Open"},{"key":"10.1016\/j.jpeds.2022.12.016_bib19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1164\/rccm.200607-883OC","article-title":"Standard reference for the six-minute-walk test in healthy children aged 7 to 16 years","volume":"176","author":"Li","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jpeds.2022.12.016_bib20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jpeds.2006.12.052","article-title":"Six-minute walk test in children and adolescents","volume":"150","author":"Geiger","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2022.12.016_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jpeds.2022.12.016_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/j.gastro.2007.05.029","article-title":"Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study","volume":"133","author":"Turner","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jpeds.2022.12.016_bib23","first-page":"439","article-title":"Development and validation of a pediatric Crohn's disease activity index","volume":"12","author":"Hyams","year":"1991","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jpeds.2022.12.016_bib24","series-title":"Nelson Textbook of pediatrics","author":"Kliegman","year":"2020"},{"key":"10.1016\/j.jpeds.2022.12.016_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cgh.2019.04.012","article-title":"Development and validation of the mucosal inflammation noninvasive index for pediatric Crohn's disease","volume":"18","author":"Cozijnsen","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jpeds.2022.12.016_bib26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/mus.23905","article-title":"The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study","volume":"48","author":"McDonald","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jpeds.2022.12.016_bib27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpeds.2022.12.016_bib28","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/MPG.0000000000003003","article-title":"Ferric carboxymaltose across all ages in paediatric Gastroenterology shows efficacy without increased safety concerns","volume":"72","author":"Sasankan","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jpeds.2022.12.016_bib29","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00431-017-2995-8","article-title":"Retrospective review of effectiveness and safety of intravenous ferric carboxymaltose given to children with iron deficiency anaemia in one UK tertiary centre","volume":"176","author":"Tan","year":"2017","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jpeds.2022.12.016_bib30","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/ajg.2013.335","article-title":"A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED)","volume":"108","author":"Reinisch","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jpeds.2022.12.016_bib31","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1572-0241.2007.01744.x","article-title":"A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial","volume":"103","author":"Kulnigg","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jpeds.2022.12.016_bib32","first-page":"CD013529","article-title":"Interventions for treating iron deficiency anaemia in inflammatory bowel disease","volume":"1","author":"Gordon","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpeds.2022.12.016_bib33","first-page":"301","article-title":"Intravenous iron-dextran: therapeutic and experimental possibilities","volume":"100","author":"Ganzoni","year":"1970","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/j.jpeds.2022.12.016_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.blre.2017.02.004","article-title":"New insights into iron deficiency and iron deficiency anemia","volume":"31","author":"Camaschella","year":"2017","journal-title":"Blood Rev"},{"key":"10.1016\/j.jpeds.2022.12.016_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00277-019-03871-z","article-title":"Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia","volume":"99","author":"Kaundal","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jpeds.2022.12.016_bib36","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1111\/bcp.14643","article-title":"Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside-a systematic review and meta-analysis","volume":"87","author":"Schaefer","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jpeds.2022.12.016_bib37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1185\/03007995.2012.761599","article-title":"Tolerability of different oral iron supplements: a systematic review","volume":"29","author":"Cancelo-Hidalgo","year":"2013","journal-title":"Curr Med Res Opin"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347622011349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347622011349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:14:18Z","timestamp":1758359658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347622011349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":37,"alternative-id":["S0022347622011349"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2022.12.016","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ferric Carboxymaltose Versus Ferrous Fumarate in Anemic Children with Inflammatory Bowel Disease: The POPEYE Randomized\u00a0Controlled Clinical\u00a0Trial","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2022.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}